I am an independent consultant specializing in commercial analytics and forecasting for pharmaceutical and life sciences companies. With over 20 years of experience — including the past 7 as an independent advisor — I help teams make confident, data-driven decisions from pre-launch through in-market optimization.
Clients such as Amgen, Gilead, AbbVie, Genentech, Lilly, and Sanofi rely on me for rigorous analytics, clear insights, and fit-for-purpose solutions. My work spans oncology, rare diseases, and specialty therapeutics, often addressing high-stakes questions with significant business impact.
I’m known for quickly stepping in, integrating seamlessly with internal teams, and delivering high-quality work without the learning curve. Whether leading a complex forecast, designing market research, or synthesizing diverse data sources, I bring a collaborative, results-focused approach that helps clients move forward with clarity and confidence.
Before launching my independent consulting practice, I led strategic projects in life sciences at Komodo Health, Precision Health Economics, and ZS Associates, and in healthcare delivery at Stanford, HHS/ASPE, and RAND. I earned my MBA from Harvard Business School and graduated magna cum laude from UC Berkeley on a full scholarship.
Built Excel models covering 20 countries and multiple scenarios to guide global launch strategy. Delivered clear, actionable insights for executive decision-making.
Led the design and analysis of multi-country physician research, incorporating conjoint and scenario-based approaches to forecast product uptake.
Developed fit-for-purpose models to evaluate multiple market entry strategies, enabling leadership to select the optimal path forward.
lily@rockstrategy.com | (650) 485-1043 | Southern California